Featured Research

from universities, journals, and other organizations

To combat deadly brain cancer, target the stem cells

Date:
July 8, 2011
Source:
Cell Press
Summary:
Researchers have uncovered a new target that could stop the growth of glioblastoma, a deadly form of brain cancer. A new study identifies an enzyme found in glioma stem cells that allows them to grow and seed tumors. Importantly, normal stem cells, including those in the brain, don't appear to share that same dependency.

Researchers have uncovered a new target that could stop the growth of glioblastoma, a deadly form of brain cancer. In the July 8th issue of the journal Cell, a Cell Press publication, a new study identifies an enzyme found in glioma stem cells that allows them to grow and seed tumors. Importantly, normal stem cells, including those in the brain, don't appear to share that same dependency.

"When thinking about therapeutics [targeting cancer stem cells], you have to be careful that you aren't interfering with normal stem cells," said Christine Eyler of the Cleveland Clinic. "Glioma stem cells are not derived from normal stem cells but they do share many features with them. The trick to therapy is to find pathways exhibited only by cancer stem cells."

The goal of Eyler's team, led by Cleveland Clinic scientist Jeremy Rich, was to identify just such a pathway in glioma stem cells, a particularly devastating form of brain cancer. Despite modern surgical and medical therapies, those diagnosed with a glioblastoma have a median survival of just over a year.

Previous work identifying glioma cells with stem-cell like behavior and demonstrating the propagation of gliomas in animals offered hope for the development of anti-glioma therapeutics. The challenge, however, has been finding pathways that differ between glioma and normal stem cells in spite of evidence that the glioma stem cells closely resemble embryonic and neural stem cells.

Earlier studies led the researchers to investigate the pathway that produces nitric oxide (NO), a molecule thought to support tumors' growth and resistance to treatment. Those experiments showed that glioma cells express varying levels of nitric oxide synthases, critical enzymes in that pathway.

"It's important to note that there are different forms of nitric oxide synthases," said Anita Hjelmeland, also at the Cleveland Clinic. "We focused on one that is well restricted to glioma stem cells."

In the current study, the authors use mouse models of glioma to show that glioma stem cells have elevated levels of nitric oxide synthase-2 (NOS2). This leads to exess production of NO, which, in turn, endows stem cells with the ability to growand seed tumors.

These findings have real clinical relevance, the researchers say. They found that high NOS2 levels correlate with decreased survival in patients with glioma. Moreover, treatments designed to block NOS2 in the brain slow the growth of brain tumors in mice.

Notably, NOS2 inhibitors have already been tested in clinical trials for other treatments. "The exciting part is the drugs have already been given to people," Eyler said, and it appears they have little toxicity.

NOS2 inhibitors could be a welcome addition to therapies in use for gliomas today. "If you target the tumor as a whole, you may get rid of most cells but leave the stem cells behind," Hjelmeland said. But if you only target cancer stem cells and leave the rest intact, tumors may continue to grow. By combining approaches, "you'll have a better therapy."

Eyler said she wouldn't be surprised if the nitric oxide pathway uncovered in glioma stem cells might also prove to be important in other forms of cancer. The researchers also continue to look for other pathways unique to cancer stem cells.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Journal Reference:

  1. Christine E. Eyler, Qiulian Wu, Kenneth Yan, Jennifer M. MacSwords, Devin Chandler-Militello, Katherine L. Misuraca, Justin D. Lathia, Michael T. Forrester, Jeongwu Lee, Jonathan S. Stamler et al. Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2. Cell, Volume 146, Issue 1, 53-66, 8 July 2011 DOI: 10.1016/j.cell.2011.06.006

Cite This Page:

Cell Press. "To combat deadly brain cancer, target the stem cells." ScienceDaily. ScienceDaily, 8 July 2011. <www.sciencedaily.com/releases/2011/07/110707121916.htm>.
Cell Press. (2011, July 8). To combat deadly brain cancer, target the stem cells. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2011/07/110707121916.htm
Cell Press. "To combat deadly brain cancer, target the stem cells." ScienceDaily. www.sciencedaily.com/releases/2011/07/110707121916.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

More Coverage


Brain Tumor Discovery Could Lead to New Treatment

July 8, 2011 Researchers have identified a cellular pathway that cancer stem cells use to promote tumor growth in malignant glioma, an aggressive brain tumor. The research also found that existing medications ... read more
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins